Home / Health / Heart Benefits Vanish After Stopping GLP-1 Drugs
Heart Benefits Vanish After Stopping GLP-1 Drugs
18 Mar
Summary
- Heart benefits from GLP-1 drugs disappear rapidly after stopping treatment.
- Cardiovascular risks return within six months of discontinuing medication.
- Study highlights the need for continuous GLP-1 use to maintain heart health.
Injected GLP-1 medications offer substantial reductions in heart attack and stroke risk, but these cardiovascular benefits are temporary. A recent large-scale study published in BMJ Medicine indicates that these protective effects vanish quickly upon cessation of the drugs.
Researchers found that heart risks start to rebound within six months after patients stop taking GLP-1s. Within approximately 1.5 years, the initial benefits are nearly entirely reversed, a phenomenon described as "metabolic whiplash." This reversal happens significantly faster than the time it took to accrue the benefits in the first place.
The study analyzed over 333,000 patient records from the Veterans Health Administration, comparing GLP-1 users to those on sulfonylureas. Those who stopped GLP-1s experienced a 4% increase in heart risks at six months, rising to 22% by the second year off the medication compared to continuous users.
Experts suggest this underscores the importance of consistent treatment to preserve cardiovascular gains. Many patients discontinue these medications due to side effects or cost, with about half stopping within a year. Insurers are urged to recognize the long-term necessity of these drugs for maintaining heart health.
